CompletedNot Applicable

Radiofrequency (RF) Ablation Prospective Outcomes Study

United States298 participantsStarted 2020-12-22

Plain-language summary

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

Who can participate

Age range0 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Key Inclusion Criteria: * Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain per local Directions for Use (DFU) * Signed a valid, IRB/EC/REB-approved informed consent form Key Exclusion Criteria: * Meets any contraindications per locally applicable Directions for Use (DFU) * Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

What they're measuring

Patient Global Impression of Change (PGIC)

Timeframe: 12-months post-procedure

Trial details

NCT IDNCT04673032

SponsorBoston Scientific Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-02-07

Results submitted2026-02-02

View on ClinicalTrials.gov More Pain, Chronic trials